SCHEMBL3956552

SCHEMBL3956552

Nc1nc(-c2cccc3ncccc23)cc(CCc2ccccc2)c1N

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ATR Q13535 1/20 0.43
DHFR P00374 1/20 0.41
BACE1 P56817 1/20 0.41
P2RX7 Q99572 1/20 0.41
FTO Q9C0B1 1/20 0.40
KDM5B Q9UGL1 1/20 0.40
KDM2A Q9Y2K7 1/20 0.40
BPTF Q12830 1/20 0.39
NSD2 O96028 1/20 0.39
KDM4E B2RXH2 2/20 0.39
TGFBR1 P36897 2/20 0.37
USP2 O75604 1/20 0.37
ALOX15 P16050 1/20 0.37
TSHR P16473 1/20 0.37
HTT P42858 1/20 0.37
L3MBTL1 Q9Y468 1/20 0.37
ABCB1 P08183 1/20 0.37
HTR2C P28335 1/20 0.36
APP P05067 2/20 0.36
AKT1 P31749 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL482232 0.74 ATR (0.43) ATRP2RX7FTOKDM5BKDM2A
SCHEMBL11380914 0.71 ABCB1 (0.48) DHFRBACE1KDM4EHTTABCB1
SCHEMBL3955754 0.70 APP (0.54) KDM4EHTTL3MBTL1APP
SCHEMBL3955508 0.70 ATR (0.49) ATRHTTL3MBTL1APP
SCHEMBL481930 0.70 ATR (0.59) ATRFTOKDM5BKDM2ABPTF
SCHEMBL11373715 0.69 SYK (0.53) ATRDHFRBACE1KDM4ETGFBR1
SCHEMBL10483392 0.69 LOXL2 (0.58) KDM4EHTTABCB1APP
SCHEMBL30746358 0.69 LOXL2 (0.58) KDM4EHTTABCB1APP
SCHEMBL482214 0.68 ATR (0.51) ATRP2RX7TGFBR1TSHRHTT
SCHEMBL15757397 0.67 CDC7 (0.60) ATRFTOKDM5BKDM2ABPTF

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2078016-A2 HETEROARYL COMPOUNDS, COMPOSITIONS THEREOF, AND METHODS OF TREATMENT THEREWITH Signal Pharmaceuticals LLC (US) 2009-07-15 EP disclosed
WO-2008051493-A2 HETEROARYL COMPOUNDS, COMPOSITIONS THEREOF, AND THEIR USE AS PROTEIN KINASE INHIBITORS SIGNAL PHARMACEUTICALS, LLC (US) 2008-05-02 WO disclosed